Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells

I Sehgal, J Bailey, K Hitzemann, MR Pittelkow and NJ Maihle

Department of Molecular Biology, Mayo Foundation, Rochester, Minnesota 55905.

Amphiregulin is a heparin-binding epidermal growth factor (EGF)-related peptide that binds to the EGF receptor (EGF-R) with high affinity. In this study, we report a role for amphiregulin in androgen-stimulated regulation of prostate cancer cell growth. Androgen is known to enhance EGF-R expression in the androgen-sensitive LNCaP human prostate carcinoma cell line, and it has been suggested that androgenic stimuli may regulate proliferation, in part, through autocrine mechanisms involving the EGF-R. In this study, we demonstrate that LNCaP cells express amphiregulin mRNA and peptide and that this expression is elevated by androgenic stimulation. We also show that ligand-dependent EGF-R stimulation induces amphiregulin expression and that androgenic effects on amphiregulin synthesis are mediated through this EGF-R pathway. Parallel studies using the estrogen-responsive breast carcinoma cell line, MCF-7, suggest that regulation of amphiregulin by estrogen may also be mediated via an EGF-R pathway. In addition, heparin treatment of LNCaP cells inhibits androgen-stimulated cell growth further suggesting that amphiregulin can mediate androgen- stimulated LNCaP proliferation. Together, these results implicate an androgen-regulated autocrine loop composed of amphiregulin and its receptor in prostate cancer cell growth and suggest that the mechanism of steroid hormone regulation of amphiregulin synthesis may occur through androgen upregulation of the EGF-R and subsequent receptor- dependent pathways.

Volume 5, Issue 3, pp. 339-347, 03/01/1994
Copyright © 1994 by The American Society for Cell Biology

This article has been cited by other articles:

				C. C. Johansson, A. Yndestad, J. M. Enserink, A. H. Ree, P. Aukrust, and K. Tasken The Epidermal Growth Factor-Like Growth Factor Amphiregulin Is Strongly Induced by the Adenosine 3',5'-Monophosphate Pathway in Various Cell Types Endocrinology, November 1, 2004; 145(11): 5177 - 5184. [Abstract] [Full Text] [PDF]

				C. D. Wolfgang, M. Essand, B. Lee, and I. Pastan T-Cell Receptor {gamma} Chain Alternate Reading Frame Protein (TARP) Expression in Prostate Cancer Cells Leads to an Increased Growth Rate and Induction of Caveolins and Amphiregulin Cancer Res., November 1, 2001; 61(22): 8122 - 8126. [Abstract] [Full Text] [PDF]

				R. M. Adam, J. G. Borer, B. J. Williams, J. A. Eastham, K. R. Loughlin, and M. R. Freeman Amphiregulin Is Coordinately Expressed with Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Interstitial Smooth Muscle of the Human Prostate Endocrinology, December 1, 1999; 140(12): 5866 - 5875. [Abstract] [Full Text]

				L. Wong, T. B. Deb, S. A. Thompson, A. Wells, and G. R. Johnson A Differential Requirement for the COOH-terminal Region of the Epidermal Growth Factor (EGF) Receptor in Amphiregulin and EGF Mitogenic Signaling J. Biol. Chem., March 26, 1999; 274(13): 8900 - 8909. [Abstract] [Full Text] [PDF]

				S. A. Thompson, A. Harris, D. Hoang, M. Ferrer, and G. R. Johnson COOH-terminal Extended Recombinant Amphiregulin with Bioactivity Comparable with Naturally Derived Growth Factor J. Biol. Chem., July 26, 1996; 271(30): 17927 - 17931. [Abstract] [Full Text] [PDF]